u/controversial_only

The controversial formula is the interesting one and I want to explain why for anyone who skimmed it.

A naive controversy score is just "closest to 50/50", which surfaces every comment with two upvotes and two downvotes. Multiplying by total volume means you get the arguments people actually turned up for. It is the only sort on this site that reliably finds threads where the community genuinely does not agree, as opposed to threads where nobody cared.

Careful — posting a log as a schedule for other people to follow is not what this board is for.

External review was the thing that finally worked. I did not know it existed until a thread on this board.

That method was developed for a different compound class and would not resolve the impurities you are asking about.

sorted by controversial as always: I think the wiki is genuinely bad and that's the actual reason people don't use it instead of asking, not a visibility problem

What did the intake actually ask you?

Correction: those two entries are 8 weeks apart, not consecutive, which changes how the middle of that series reads.

Push back: a log with four variables changing at once cannot attribute anything to any of them.

Agreed — and the payoff genuinely arrives in month six, not week two.

retrospective logs drift, contemporaneous ones do not

Was this a denied authorization or a rejected claim?

Has a peer-to-peer been offered or requested?

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

the habits are what has to carry it afterwards

ask for the denial reason in writing, always

This is the whole method. Answer the criterion they named, not the decision in general.

Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.

Asked for potency testing on the finished preparation. They had it. I had assumed they would not.

Kept a log purely because so few people are logging this one. It is one person and it is not data.

Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.

Yes. Anyone reading this board should hold their conclusions loosely until phase 3 reports.

Same. A quiet fortnight after stopping tells you very little; the interesting part starts later.

That result is preclinical. Worth flagging, since the thread has been reading it as human data.

Disagree — a 503B being registered does not make its preparations equivalent to an approved product. Different regulatory category entirely.

That is an employer plan process, and the provincial route is different in both form and timeline.

private plans and provincial plans are different fights entirely

a template letter that quotes their own criteria back is the strongest one

Has anyone here tested that compound at all?

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

What are you planning to watch for, and over what period?

stopping abruptly and stopping gradually are different experiences

amylin analogue, different receptor family, different story

decide what you are watching for before you stop

Why step therapy denials feel unfair and are nonetheless beatable.

The requirement is that documented trials of preferred alternatives exist. It is a record-keeping standard, not a clinical judgement about you, which is why arguing the clinical merits rarely moves it and producing dates and durations often does.

What to assemble: what was tried, at what dose, for how long, and what the documented outcome was. A one-page table with dates beats three pages of prose every time. Where a trial is contraindicated rather than simply unsuccessful, that needs to be stated explicitly by the prescriber in those terms.

None of this is legal or medical advice — it is what the threads here have found works.

handling and storage vary enormously across this catalogue

the second-level appeal is where things actually turn

Did the consultation ask about history and medication?

Which nation, and which ICB if you are in England?

Which pharmacy, and what did they quote for the month rather than the first month?

Australia or New Zealand?

Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.